Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HempFusion was a consumer wellness company focused on hemp-derived CBD products, probiotics, and topical wellness brands rather than a drug-development biotech pipeline. The company marketed broad-spectrum hemp extract tinctures, capsules, gummies, creams, and function-specific wellness products, and also owned brands including Probulin Probiotics, Sagely Naturals, and Apothecanna. HempFusion emphasized regulatory compliance, third-party testing, DNA-validated European hemp sourcing, and a proprietary solvent-free CO2 extraction process branded as HempOnePassExtraction (HOPE). Although its consumer brand website remains online, the public company disclosed in 2023 that it had ceased manufacturing, research and development operations, terminated most employees, and stopped shipping products while exploring bankruptcy and insolvency options. As a result, it is best characterized as a defunct public cannabinoid wellness company rather than an active life sciences developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HempFusion.